🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

10 recruiting trials

for Leber Hereditary Optic Disease

Gene Therapy Clinical Trial for the Treatment Of Leber's HereDitary Optic Neuropathy NCT04912843Phase 2, Phase 31 site📍 Beijing Wuhan Neurophth Biotechnology Limited Company · Tests: NR082 injection, Sham Injection Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168n/a1 site📍 Sioux Falls Sanford Health New Non-invasive Modalities for Assessing Retinal Structure and Function NCT03475173NA1 site📍 Iowa City Randy Kardon · Tests: LSFG-NAVI North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC) NCT01694940n/a17 sites📍 San Diego📍 Stanford📍 Aurora Columbia University Efficacy and Safety Study of Bilateral IVT Injection of GS010 at Two Dose Levels in LHON Patients NCT07303296Phase 21 site📍 Paris GenSight Biologics · Tests: GS010 High dose, GS010 Low dose Stem Cell Ophthalmology Treatment Study II NCT03011541NA4 sites📍 Westport📍 Coral Springs📍 Vienna MD Stem Cells · Tests: Arm 1 Study to Evaluate Sepofarsen in Subjects With Leber Congenital Amaurosis (LCA) Type 10 (HYPERION) NCT06891443Phase 318 sites📍 San Francisco📍 Miami📍 Iowa City Laboratoires Thea · Tests: sepofarsen, Placebo IVT Metabolomics Analysis According to the Retinal Nerve Fiber Layer in Patients With NOHL Mutations (MétabOCT) NCT06682819NA1 site📍 Paris Hôpital Necker-Enfants Malades · Tests: Optical coherent tomography Safety and Tolerability of Subretinal OPGx-RDH12-1001 for LCA-Associated Inherited Retinal Degeneration (LCA-IRD) NCT07681778Phase 1, Phase 24 sites📍 Phoenix📍 Philadelphia📍 Dallas Opus Genetics, Inc · Tests: OPGx-RDH12 Inherited Retinal Degenerative Disease Registry NCT02435940n/a1 site📍 Columbia Foundation Fighting Blindness
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy